415 related articles for article (PubMed ID: 24532422)
21. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
[TBL] [Abstract][Full Text] [Related]
22. Ultrasonography as a tool for monitoring the development and progression of cholangiocarcinoma in Opisthorchis viverrini/ dimethylnitrosamine-induced hamsters.
Plengsuriyakarn T; Eursitthichai V; Labbunruang N; Na-Bangchang K; Tesana S; Aumarm W; Pongpradit A; Viyanant V
Asian Pac J Cancer Prev; 2012; 13(1):87-90. PubMed ID: 22502719
[TBL] [Abstract][Full Text] [Related]
23. Involvement of c-Ski oncoprotein in carcinogenesis of cholangiocacinoma induced by Opisthorchis viverrini and N-nitrosodimethylamine.
Boonmars T; Wu Z; Boonjaruspinyo S; Puapairoj A; Kaewsamut B; Nagano I; Pinlaor S; Yongvanit P; Wonkchalee O; Juasook A; Sudsarn P; Srisawangwong T
Pathol Oncol Res; 2011 Jun; 17(2):219-27. PubMed ID: 20853076
[TBL] [Abstract][Full Text] [Related]
24. Behavior-related risk factors for opisthorchiasis-associated cholangiocarcinoma among rural people living along the mekong river in five greater mekong subregion countries.
Songserm N; Charoenbut P; Bureelerd O; Pintakham K; Woradet S; Vanhnivongkham P; Cua LN; Uyen NTT; Cuu NC; Sripa B
Acta Trop; 2020 Jan; 201():105221. PubMed ID: 31654901
[TBL] [Abstract][Full Text] [Related]
25. Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
Churi CR; Shroff R; Wang Y; Rashid A; Kang HC; Weatherly J; Zuo M; Zinner R; Hong D; Meric-Bernstam F; Janku F; Crane CH; Mishra L; Vauthey JN; Wolff RA; Mills G; Javle M
PLoS One; 2014; 9(12):e115383. PubMed ID: 25536104
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and Control of Opisthorchis viverrini Infection: Implications for Cholangiocarcinoma Prevention.
Khuntikeo N; Thinkhamrop B; Crellen T; Eamudomkarn C; Petney TN; Andrews RH; Sithithaworn P
Recent Results Cancer Res; 2023; 219():27-52. PubMed ID: 37660330
[TBL] [Abstract][Full Text] [Related]
27. Plasma phosphoproteome and differential plasma phosphoproteins with opisthorchis viverrini-related cholangiocarcinoma.
Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K
Asian Pac J Cancer Prev; 2015; 16(3):1011-8. PubMed ID: 25735322
[TBL] [Abstract][Full Text] [Related]
28. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
29. Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta as a potential biomarker for
Prasopdee S; Yingchutrakul Y; Roytrakul S; Pholhelm M; Phanaksri T; Kunjantarachot A; Kulsantiwong J; Butthongkomvong K; Tesana S; Sathavornmanee T; Thitapakorn V
Parasitology; 2022 Feb; 149(2):171-180. PubMed ID: 35234600
[TBL] [Abstract][Full Text] [Related]
30. Update on the risk factors for opisthorchiasis and cholangiocarcinoma in Thailand.
Prasopdee S; Rojthongpond T; Chitkoolsamphan Y; Pholhelm M; Yusuk S; Pattaraarchachai J; Butthongkomvong K; Kulsantiwong J; Phanaksri T; Kunjantarachot A; Tesana S; Sathavornmanee T; Thitapakorn V
Parasites Hosts Dis; 2023 Nov; 61(4):463-470. PubMed ID: 38043542
[TBL] [Abstract][Full Text] [Related]
31. Liver fluke granulin promotes extracellular vesicle-mediated crosstalk and cellular microenvironment conducive to cholangiocarcinoma.
Arunsan P; Chaidee A; Cochran CJ; Mann VH; Tanno T; Kumkhaek C; Smout MJ; Karinshak SE; Rodpai R; Sotillo J; Loukas A; Laha T; Brindley PJ; Ittiprasert W
Neoplasia; 2020 May; 22(5):203-216. PubMed ID: 32244128
[TBL] [Abstract][Full Text] [Related]
32. Suppression of Ov-grn-1 encoding granulin of Opisthorchis viverrini inhibits proliferation of biliary epithelial cells.
Papatpremsiri A; Smout MJ; Loukas A; Brindley PJ; Sripa B; Laha T
Exp Parasitol; 2015 Jan; 148():17-23. PubMed ID: 25450776
[TBL] [Abstract][Full Text] [Related]
33. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group.
Loilome W; Yooyuen S; Namwat N; Sithithaworn P; Puapairoj A; Kano J; Noguchi M; Miwa M; Yongvanit P
Tumour Biol; 2012 Dec; 33(6):2289-98. PubMed ID: 22922884
[TBL] [Abstract][Full Text] [Related]
34. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis.
Loilome W; Wechagama P; Namwat N; Jusakul A; Sripa B; Miwa M; Kuver R; Yongvanit P
Parasitol Int; 2012 Mar; 61(1):136-9. PubMed ID: 21763455
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanism of cholangiocarcinoma carcinogenesis.
Maemura K; Natsugoe S; Takao S
J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):754-60. PubMed ID: 24895231
[TBL] [Abstract][Full Text] [Related]
36. Altered Expression of Oxidative Metabolism Related Genes in Cholangiocarcinomas.
Aukkanimart R; Boonmars T; Juasook A; Sriraj P; Boonjaraspinyo S; Wu Z; Laummuanwai P; Pairojkul C; Khuntikeo N; Rattanasuwan P
Asian Pac J Cancer Prev; 2015; 16(14):5875-81. PubMed ID: 26320466
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for cholangiocarcinoma in the lower part of Northeast Thailand: a hospital-based case-control study.
Manwong M; Songserm N; Promthet S; Matsuo K
Asian Pac J Cancer Prev; 2013; 14(10):5953-6. PubMed ID: 24289607
[TBL] [Abstract][Full Text] [Related]
38. iNOS-dependent DNA damage via NF-kappaB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antihelminthic drug praziquantel.
Pinlaor S; Hiraku Y; Yongvanit P; Tada-Oikawa S; Ma N; Pinlaor P; Sithithaworn P; Sripa B; Murata M; Oikawa S; Kawanishi S
Int J Cancer; 2006 Sep; 119(5):1067-72. PubMed ID: 16570287
[TBL] [Abstract][Full Text] [Related]
39. Cholangiocarcinoma: lessons from Thailand.
Sripa B; Pairojkul C
Curr Opin Gastroenterol; 2008 May; 24(3):349-56. PubMed ID: 18408464
[TBL] [Abstract][Full Text] [Related]
40. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression.
Dokduang H; Techasen A; Namwat N; Khuntikeo N; Pairojkul C; Murakami Y; Loilome W; Yongvanit P
J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):767-76. PubMed ID: 25044480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
